Shionogi obtains settlement entitling it to royalties on European Union sales of drug for treatment of fatal lung disease
Clients Shionogi & Co., Ltd.
Jones Day represented Shionogi & Co., Ltd. in a royalty dispute with InterMune, Inc. concerning sales of Esbriet® for treatment of Idiopathic Pulmonary Fibrosis ("IPF"), obtaining a settlement entitling Shionogi to royalties on InterMune's sales in the European Union.
Shionogi & Co., Ltd. v. InterMune, Inc., Case No. 3:12-cv-03495-EDL (N.D. Cal.)